Purixan
Term · Oncology and biomedicine · MLC-T-ONC-007099
A drug used with other drugs to treat adults and children with acute lymphoblastic leukemia. It is also being studied in the treatment of other types of cancer. Purixan stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called mercaptopurine and Purinethol.
| Identifier | MLC-T-ONC-007099 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | mercaptopurine; Purinethol |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007099",
"term": "Purixan",
"field": "Oncology and biomedicine",
"definition": "A drug used with other drugs to treat adults and children with acute lymphoblastic leukemia. It is also being studied in the treatment of other types of cancer. Purixan stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called mercaptopurine and Purinethol.",
"synonyms": [
"mercaptopurine",
"Purinethol"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/purixan/"
}
Record 13,888 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.